Long intergenic non-protein coding RNA 1819 (LINC01819)

Long intergenic non-protein coding RNA 1819 (LINC01819) is a human long intergenic non-coding RNA (lincRNA), which means it is a transcript longer than 200 nucleotides that does not overlap known protein-coding genes[1]. LincRNAs broadly function to fine-tune gene expression by influencing chromatin architecture, regulating transcription (both as enhancer-like elements and through direct binding), and stabilizing RNAs[1]. These molecules often display high tissue specificity and may modulate neighboring or distant gene expression both in *cis* and *trans*[1]. While the molecular and disease associations of many lincRNAs have been described—especially roles in gene regulation and cancer biology—there is currently no published evidence that LINC01819 itself is established as a therapeutic target, nor are there any specific small-molecule or biological drugs known to act on it directly[1][2][4]. Some lincRNAs are explored as cancer biomarkers or functional regulators, but for LINC01819, such applications are not currently substantiated in the scientific literature.

Other names

AC016735.2KPRT4KLF5 positively regulated transcript 4LINC02590long intergenic non-protein coding RNA 2590